As changes in DCE-MRI occur within 1 week of anti-VEGF therapy (Ferl et al, 2015) and the xenografts show rapid changes, it should be a priority to examine short-term induced adaptations to help determine the most appropriate therapy for the adapted tumour, by imaging or biopsies, or peripheral blood markers. This evidence concerns the gene VEGFA and neoplasm.